[{"Assets_0_Q1_USD":295333000.0,"CommonStockSharesOutstanding_0_Q1_shares":62254091.0,"NetIncomeLoss_1_Q1_USD":-38958000.0,"StockholdersEquity_0_Q1_USD":165887000.0,"Ticker":"DVAX","CIK":"1029142","name":"DYNAVAX TECHNOLOGIES CORP","OfficialName":"Dynavax Technologies Corporation Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1279198792.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]